Old Web
English
Sign In
Acemap
>
Paper
>
Potential cancer risk with omalizumab: a disproportionality analysis of the WHO’s VigiBase pharmacovigilance database
Potential cancer risk with omalizumab: a disproportionality analysis of the WHO’s VigiBase pharmacovigilance database
2021
Diogo Mota
Tiago Azenha Rama
Milton Severo
André Moreira
Keywords:
Intensive care medicine
cancer risk
Pharmacovigilance
Omalizumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]